• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN MFG SOLUTIONS S.A. PERITONEAL CATHETER; CATHETER, PERITONEAL, LONG-TERM INDWELLING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN MFG SOLUTIONS S.A. PERITONEAL CATHETER; CATHETER, PERITONEAL, LONG-TERM INDWELLING Back to Search Results
Model Number PERITONEAL CATHETER
Device Problem Product Quality Problem (1506)
Patient Problems Peritonitis (2252); No Code Available (3191)
Event Date 11/23/2018
Event Type  Injury  
Manufacturer Narrative
(b)(4).Title: early start peritoneal dialysis: technique survival in long-term follow-up source: kidney blood press res: 2018;43:1699-1705, online publication: 23 november 2018.If information is provided in the future, a supplemental report will be issued.
 
Event Description
According to the literature source of study which compared technique survival in a cohort of patients who started either early (defined as break-in period from 3 or 14 days after catheter insertion with no previous nephrologist follow up or patient/family training) or planned (defined as break-in period of more than 14 days after catheter placement regardless of previous nephrologist follow up) peritoneal dialysis (pd).A total of 154 patients initiated pd during the study period, 40 of which was early start pd.All patients were treated with lactate-buffered glucose dialysate.There were two different brands of machine in which the pd was performed either by the two.Comparing early vs.Planned-start groups, there were no differences regarding pd dropout for peritonitis.Less patients in early start group quit pd for peritoneal membrane failure in comparison to planned-start group.In multivariate cox-regression analysis, the only factors independently associated with technique failure were bmi and diabetes mellitus, whereas no differences regarding early vs.Planned-pd start were observed.Despite the adverse scenario for initiating dialysis, early start pd had similar outcomes in comparison to planned-start pd, after a relatively long follow-up period.This study brings one more piece of evidence to support pd as an alternative treatment for renal replacement therapy in the context of urgent/early start dialysis.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PERITONEAL CATHETER
Type of Device
CATHETER, PERITONEAL, LONG-TERM INDWELLING
Manufacturer (Section D)
COVIDIEN MFG SOLUTIONS S.A.
edificio b20, calle #2
alajuela 20101
CR  20101
Manufacturer (Section G)
COVIDIEN MFG SOLUTIONS S.A.
edificio b20, calle #2
alajuela 20101
CR   20101
Manufacturer Contact
lisa hernandez
15 hampshire st.
mansfield, MA 02048
2034925563
MDR Report Key10383528
MDR Text Key202597374
Report Number3009211636-2020-00186
Device Sequence Number1
Product Code FJS
Combination Product (y/n)N
Reporter Country CodeBR
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,literature
Reporter Occupation Other
Type of Report Initial
Report Date 08/10/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/10/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberPERITONEAL CATHETER
Device Catalogue NumberPERITONEAL CATHETER
Was Device Available for Evaluation? No
Date Manufacturer Received07/23/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-